Variables | ACLF | ACLF-ETV | ACLF-ETV | ACLF-NAs |
---|---|---|---|---|
Treated | Withdrawal | Free | ||
(n = 200) | (n = 137) | (n = 47) | (n = 16) | |
ACLF etiology | ||||
Acute hepatic insult, n (%) | ||||
Alcoholic hepatitis | 38 (27.74%) | 4 (25.00%) | ||
HBV reactivation | 47 (100%) | |||
Bacterial infection | 89 (64.96%) | 9 (56.25%) | ||
Others | 10 (7.30%) | 3 (18.75%) | ||
Clinic events, n (%) | ||||
Ascites | 200 (100%) | 137 (100%) | 47 (100%) | 16 (100%) |
Jaundice | 200 (100%) | 137 (100%) | 47 (100%) | 16 (100%) |
AKI | 49 (24.50%) | 28 (20.44%) | 17 (36.17%) | 4 (25.00%) |
HE | 71 (35.50%) | 46 (33.58%) | 20 (42.55%) | 5 (31.25%) |
Acute variceal bleed | 26 (13.00%) | 15 (10.95%) | 9 (19.15%) | 2 (12.50%) |
SBP | 15 (7.50%) | 9 (6.57%) | 5 (10.64%) | 1 (6.25%) |
Organ failure | ||||
Kidney, n (%) | 19 (9.50%) | 12 (8.76%) | 5 (10.64%) | 2 (12.50%) |
Cerebral, n (%) | 33 (16.50%) | 20 (14.60%) | 10 (21.28%) | 3 (18.75%) |
Coagulation, n (%) | 70 (35.00%) | 46 (33.58%) | 19 (40.43%) | 5 (31.25%) |
Circulation, n (%) | 25 (12.50%) | 16 (11.68%) | 7 (14.89%) | 2 (12.50%) |
Lung, n (%) | 60 (30.00%) | 38 (27.74%) | 17 (36.17%) | 5 (31.25%) |